- Generic name
- Ambrisentan
- Strength
- 10 mg
- Dosage form
- Tablet
- Manufactured by
- Square Pharmaceuticals PLC.
Ambrisan 10 Tablet
About Ambrisan 10 Tablet
Ambrisan 10 is a 10 mg tablet made by Square Pharmaceuticals PLC. It contains ambrisentan and is used in adults with pulmonary arterial hypertension, a type of high blood pressure in the lungs.
There are 4 brands of Ambrisentan listed in Bangladesh.
What is Ambrisan 10 Tablet?
Ambrisan 10 is a 10 mg tablet containing the medicine ambrisentan. It belongs to a group of medicines that act on endothelin receptors in the blood vessels. It is prescribed for adults with pulmonary arterial hypertension, where blood pressure in the lungs is raised. In this condition it is used to help improve the ability to exercise and to delay worsening of the disease. Whether it suits a particular person depends on their overall health and other conditions, so the treating doctor decides if it is appropriate.
Uses of Ambrisan 10
Ambrisan 10 is used in adults for pulmonary arterial hypertension. This is a condition in which blood pressure in the arteries of the lungs is higher than normal. Treatment with ambrisentan aims to improve how well a person can exercise and to delay the disease getting worse. It is not a general treatment for everyday high blood pressure. Your doctor will assess your condition and decide whether this medicine is suitable for you.
How to use Ambrisan 10
Ambrisan 10 is a tablet that is swallowed, and it can be taken with or without food. The dose and how long you take it are decided by your doctor, who will also adjust treatment based on how you respond and tolerate it. Do not change the dose yourself. If you miss a dose, ask your doctor or pharmacist what to do rather than doubling up. Keep all follow-up appointments so your progress can be checked.
Side effects of Ambrisan 10
Some people may notice side effects while taking ambrisentan. Fluid retention, such as swelling of the ankles or legs, is a known effect of medicines in this group and can also be a sign of the underlying condition getting worse. Changes in blood counts, including a fall in haemoglobin, have been seen with this type of medicine. Tell your doctor about swelling, breathlessness or unusual tiredness. Your doctor or pharmacist can explain what to watch for and how side effects are managed.
Safety and precautions
Ambrisan 10 must not be used during pregnancy, and pregnancy should be ruled out before starting it and prevented during treatment and for a period after stopping. It is not recommended while breastfeeding. It should not be used in people with idiopathic pulmonary fibrosis. Swelling and sudden breathlessness during treatment need medical attention. Your doctor will consider your liver and blood counts before and during treatment. Tell your doctor about all other medicines you take, and ask them first if you have any doubts about whether it is right for you.
Frequently asked questions
What is Ambrisan 10 used for and what kind of medicine is it?
It is used in adults with pulmonary arterial hypertension, a raised blood pressure in the lungs. It is an endothelin receptor blocker that acts on the blood vessels. It is not a routine blood pressure medicine, and your doctor will decide whether it is suitable for you.
How should Ambrisan 10 be taken?
Swallow the tablet, with or without food. Your doctor decides the dose and how long you take it, and may adjust it over time. Never change the dose on your own, and ask your doctor or pharmacist what to do if you miss a dose.
What does the generic name ambrisentan mean?
Ambrisentan is the generic name of the active ingredient in Ambrisan 10. It is the name used for the medicine itself, whatever brand it comes in. Knowing the generic name helps your doctor and pharmacist check what you are taking and any interactions with other medicines.
Can I become pregnant while taking this medicine?
It must not be used in pregnancy. Pregnancy needs to be ruled out before treatment starts and prevented during treatment and for a period after stopping. If you are pregnant, think you may be, or are planning a pregnancy, speak to your doctor before taking it.
Indications
Pharmacology
The pharmacokinetics of Ambrisentan (S-Ambrisentan) in healthy subjects are dose proportional. The absolute bioavailability of Ambrisentan is not known. Ambrisentan is absorbed with peak concentrations occurring approximately 2 hours after oral administration in healthy subjects and PAH patients. Food does not affect its bioavailability. In vitro studies indicate that Ambrisentan is a substrate of P-gp. Ambrisentan is highly bound to plasma proteins (99%). The elimination of Ambrisentan is predominantly by non-renal pathways, but the relative contributions of metabolism and biliary elimination have not been well characterized. In plasma, the AUC of 4-hydroxymethyl Ambrisentan accounts for approximately 4% relative to parent Ambrisentan AUC. Thein vivo inversion of S-Ambrisentan to R-Ambrisentan is negligible. The mean oral clearance of Ambrisentan is 38 mL/min and 19 mL/min in healthy subjects and in PAH patients, respectively. Although Ambrisentan has a 15-hour terminal half-life, the mean trough concentration of Ambrisentan at steady-state is about 15% of the mean peak concentration and the accumulation factor is about 1.2 after long-term daily dosing, indicating that the effective half-life of Ambrisentan is about 9 hours.
Dosage & Administration
Pediatric patients: The safety and effectiveness of Ambrisentan in pediatric patients have not been established.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Pulmonary Veno-occlusive Disease: If patients develop acute pulmonary edema during initiation of therapy with vasodilating agents such as Ambrisentan, the possibility of pulmonary veno-occlusive disease should be considered, and if con_rmed. Ambrisentan should be discontinued.
Hematological Changes: Decreases in hemoglobin concentration and hematocrit have followed administration of other endothelin receptor antagonists and were observed in clinical studies with Ambrisentan.
Hepatic impairment: Ambrisentan is not recommended in patients with moderate or severe hepatic impairment.
Storage Conditions
Alternative brands of Ambrisentan
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.